Mauclet C, Collard P, Ghaye B, Hoton D, et al. Tumor response to EGFR/BRAF/MEK co-inhibition in a patient with EGFR mutated lung adenocarcinoma developing a BRAF(V600) mutation as an acquired resistance mechanism. Lung Cancer 2021;159:42-44.
PMID: 34304052